#EBW26: Previews: Meet the chairs for the keynote with Aneta Tyszkiewicz
The second keynote of #EBW26 will be delivered by Aneta Tyszkiewicz, Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA). The subject of the keynote will be ‘From scientific excellence to industrial leadership: Strengthening Europe’s attractiveness for research and innovation through the EU Biotech Act’. Read more about Aneta Tyszkiewicz here.
This post introduces the session chairs:
Dr. Christine Joye
Dr. Joye is the Executive Director of Swiss Biobanking Platform. She graduated from Lausanne University in health sciences with a PhD in virology in 2004. In parallel, she obtained a master in health management, and entered the exciting field of biobanks in 2005. Her experience is mainly as a reference in the development of state of the art biobanks, first in oncology in 2007, then as a centralized institutional biobank in a hospital setting in 2013.
In the Biobanking field, she implemented the first general consent for research purposes in Switzerland and was always very interested in biobank sustainability. In 2015, she took the position of the Executive Director of the national coordination platform in Switzerland for biobanking activities called Swiss Biobanking Platform, with the vision to promote access and usage of the existing and future banked bio-specimens for research purposes in the human as in the non-human fields.
Dr. Ayat Salman
Dr. Salman is currently the Operation’s Director at the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), the largest primary care electronic medical records repository in Canada and Interim Executive Operations Director for the Canadian Primary Care Research Consortium (CPCRC). Her research interest and focus are on structural and functional governance in technology as well as sociotechnical procedures in implementation science. She earned her PhD from McGill University in the Department of Family Medicine.
She has ten years of clinical research experience as a clinical research associate and six years of managerial experience at the McGill University Health Centre (MUHC). She has been a lead expert at the MUHC in biobanking since 2011 as well as internationally.
She is currently the chair of the ISO 276 (Biobanking and Biotechnology) Mirror Committee within the Standards Council of Canada. She is also an active member and a council member of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB).
Keynote details:
- Date: Thursday 21 May
- Time: 11:15 – 12:15